RT Journal Article
SR Electronic
A1 Buckley, Rita
T1 Liraglutide Leads to Increased Weight Loss Response in Patients Without Diabetes
JF MD Conference Express
YR 2015
FD SAGE Publications
VO 15
IS 4
SP 13
OP 14
DO 10.1177/1559897715583449
UL http://mdc.sagepub.com/content/15/4/13.abstract
AB Indicated for use in patients who were overweight (body mass index ≥ 27 kg/m2 with ≥ 1 comorbidities) or obese (body mass index ≥ 30 kg/m2) without diabetes mellitus, liraglutide has proven safe and effective in the SCALE–Obesity and Prediabetes trial. Combined with diet and exercise, liraglutide can improve weight and health-related quality-of-life factors.